SOX9 and ovarian carcinoma: The marked induction of cell death to the standard CDDP treatment in human ovarian cancer cells (Figure 2d,e) and complete inhibition of sphere formation (Figure 3c) and cancer cell invasion (Figure 3d) suggest the potential therapeutic effect of SOX9 silencing in human ovarian cancer.